Skip to main content

Table 4 Univariate and multivariate logistic regression analyses for Odd Ratio for occurrence of irAE

From: Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis

Factors

N

Event

Univariate

Multivariate

OR (95%CI)

p-value

OR (95%CI)

p-value

Age

  < 65

226

56

1.15 (0.72, 1.81)

0.561

–

–

  ≥ 65

188

42

1

   

Sex

 Male

287

66

0.89 (0.55, 1.44)

0.627

–

–

 Female

127

32

1

   

Smoking history

 Never

142

34

1.04 (0.60, 1.80)

0.889

–

–

 Ever

142

33

1

   

 Unknown

130

31

1.03 (0.59, 1.81)

0.906

–

–

History of hypothyroidism

 No

399

89

1

   

 Yes

15

9

5.22 (1.81, 15.07)

0.002

7.21 (2.38, 21.81)

< 0.001

Histology Subtype

 Squamous

79

21

1.21 (0.69, 2.12)

0.499

–

–

 Non-Squamous

335

77

1

   

Treatment Setting

 Clinical trial

161

53

3.17 (1.99, 5.07)

< 0.001

3.43 (2.10, 5.60)

< 0.001

 Non-clinical trial

253

39

1

 

1

 

Immunotherapy combination

 Monotherapy

322

72

1

 

1

 

 ICI + ICI

19

11

4.77 (1.85, 12.32)

0.001

5.30 (1.96, 14.33)

0.001

 ICI + Chemotherapy/others

73

15

0.90 (0.34, 5.04)

0.736

0.82 (0.42, 1.58)

0.550

  1. N number of patients, OR odd ratio, ICI immune checkpoint inhibitor